NOAC Safer for Use in Afib Ablation

ACC Conference Reporter

ACC.17 | WASHINGTON, DC — Uninterrupted anticoagulation during atrial fibrillation ablation was associated with less bleeding when using dabigatran (Pradaxa) than warfarin (Coumadin), the RE-CIRCUIT trial showed. Read More >>>

Keywords: ACC17, ACC Annual Scientific Session


< Back to Listings